|
In vitro activity of Isavuconazole against 1488 Aspergillus isolates - a pooled analysis of nine studies (click for details) |
|
|
|
Isolation of Aspergillus species from the respiratory tract
of lung transplant recipients is associated with increased
mortality (click for details) |
|
|
|
Species distribution and anti-fungal susceptibility of
Candida spp. at the Heart of England Foundation Trust,
United Kingdom (click for details) |
|
|
|
Performance of a commercial real-time PCR assay using
the ABI 7300 instrument for the detection of Aspergillus
and Pneumocystis DNA in bronchoalveolar lavage fluid
samples from critical patient (click for details) |
|
|
|
MALDI-TOF for identification of yeasts and fungi (click for details) |
|
|
|
Host factors for invasive fungal infection among patients
with haematological malignancies: a case control study (click for details) |
|
|
|
A cost-effectiveness analysis of identifying Fusobacterium
necrophorum in throat swabs followed by antibiotic
treatment to reduce the incidence of Lemierre¢s syndrome
and peritonsillar abscesses (click for details) |
|
|
|
PCR for the detection of invasive aspergillosis in
bronchoalveolar lavage systematic review and
meta-analysis (click for details) |
|
|
|
PCR for early diagnosis of invasive fungal infections in
immunocompromised patients: Where are we? (click for details) |
|
|
|
Combination of voriconazole and anidulafungin for the
treatment of triazole-resistant Aspergillus fumigatus in an
in vitro model of invasive pulmonary aspergillosis (click for details) |
|
|
